Back
Protagonist Therapeutics Vs. B. Riley Financial Industry Stock Comparison
Buy
71
PTGX
Protagonist Therapeutics
Last Price:
30.74
Seasonality Move:
16.08%
Sell
33
RILY
B. Riley Financial
Last Price:
28.27
Seasonality Move:
17.35%
Buy
71
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $30.74. The Score for PTGX is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- PTGX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
33
B. Riley Financial (RILY)
is a Sell
Is B. Riley Financial a Buy, Sell or Hold?
- The current B. Riley Financial [RILY] share price is $28.41. The Score for RILY is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- RILY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $30.74
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing selling pressure, which indicates risk of future bearish movement.
RILY Stock Price Chart
What is B. Riley Financial's stock price today?
-
The B. Riley Financial share price today is $28.41
The current trend is moderately bearish and RILY is experiencing slight selling pressure.
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.01 | Buy |
| Relative Strength Index (14 RSI): | 65.8 | Buy |
| Chaikin Money Flow: | -378836 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.92 - 29.04) | Buy |
| Bollinger Bands (100): | (24.71 - 29.41) | Buy |
RILY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.7 | Buy |
| Relative Strength Index (14 RSI): | 48.03 | Sell |
| Chaikin Money Flow: | -62987 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.47 - 35.13) | Sell |
| Bollinger Bands (100): | (17.45 - 27.95) | Buy |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.59 | Buy |
| 20-day SMA: | 27.27 | Buy |
| 50-day SMA: | 27.76 | Buy |
| 200-day SMA: | 22.41 | Buy |
| 8-day EMA: | 29.73 | Buy |
| 20-day EMA: | 28.24 | Buy |
| 50-day EMA: | 27.54 | Buy |
| 200-day EMA: | 24.11 | Buy |
RILY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.79 | Sell |
| 20-day SMA: | 31.55 | Sell |
| 50-day SMA: | 25.11 | Buy |
| 200-day SMA: | 29.92 | Sell |
| 8-day EMA: | 31.04 | Sell |
| 20-day EMA: | 30.23 | Sell |
| 50-day EMA: | 26.85 | Buy |
| 200-day EMA: | 28.63 | Sell |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $2.69 per share, an increase this year of $3.70 per share, and a decrease next year of $1.31 per share.
B. Riley Financial Earnings Growth & RILY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Protagonist Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
B. Riley Financial Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||